Stay updated on Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing v3.6.3. This indicates a minor version update to the page without changing the study details presented.
    Difference
    0.0%
    Check dated 2026-07-21T12:45:40.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.0 to v3.6.3, indicating a minor update to the page’s documentation rather than substantive changes to the study information.
    Difference
    0.0%
    Check dated 2026-06-30T01:00:21.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Recruitment status on the study page is updated to show that the study is no longer enrolling participants; new help/navigation sections are added (How to Read a Study Record, Common Questions, How to Join a Study) and the revision/version label updated to v3.6.0 with a minor header formatting change to Intervention/Treatment.
    Difference
    0.2%
    Check dated 2026-06-15T18:06:26.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.5.5 has been added, and the references to 'Prostate cancer', 'related topics:', 'MedlinePlus Genetics', and 'Revision: v3.5.4' have been removed. These changes adjust page metadata and related-topic references rather than core study content.
    Difference
    0.1%
    Check dated 2026-06-08T15:45:27.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The study record now includes Prostate cancer as an additional related topic in the MeSH terms. It also adds MedlinePlus Genetics as a related topic reference to contextualize the disease information.
    Difference
    0.1%
    Check dated 2026-06-01T09:31:45.000Z thumbnail image
  9. Check
    65 days ago
    Change Detected
    Summary
    Removed the related topics entries for 'Prostate cancer' and the 'MedlinePlus Genetics' link from the page’s related topics section. This reduces access to related informational resources without altering core study data or enrollment details.
    Difference
    0.1%
    Check dated 2026-05-25T07:37:17.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial page.